• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动患者中血管疾病影响下的中风与死亡预测

Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.

作者信息

Maan Abhishek, Shaikh Amir Y, Mansour Moussa, Ruskin Jeremy N, Heist E Kevin

机构信息

Department of Internal Medicine, University of Massachusetts Medical School, Worcester, MA 01655.

Cardiac Arrhythmia Service, Massachusetts General Hospital and Harvard Medical School, GRB 109, 55 Fruit St, Boston MA 02115.

出版信息

J Atr Fibrillation. 2012 Jun 15;5(1):586. doi: 10.4022/jafib.586. eCollection 2012 Jun-Jul.

DOI:10.4022/jafib.586
PMID:28496751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5153086/
Abstract

Atrial fibrillation (AF) is the most common arrhythmia encountered in the U.S. and the growing burden of AF has profound health implications due to the association of AF with an increased risk of stroke, heart failure, and mortality. AF is a significant risk factor for thromboembolic stroke; and also independently increases total mortality in patients with and without cardiovascular disease. Various risk stratification schemes such as CHADS and CHADS-VASc have been implemented in clinical practice to determine the risk of cardio-embolic stroke, and need for thrombo-prophylaxis in patients with AF. AF is also closely related to the pathophysiology of other cardiovascular and peripheral vascular disease. Many patients with AF have associated atherosclerosis given that many risk factors for atherosclerosis also predispose to AF. Myocardial infarction (MI) is also closely related to AF and its clinical course is affected by new onset AF. This review elucidates the impact of AF on major adverse cardiovascular events and mortality outcomes in relation to stroke, coronary artery disease and peripheral vascular disease.

摘要

心房颤动(AF)是美国最常见的心律失常,由于AF与中风、心力衰竭和死亡率增加相关,其不断增加的负担对健康具有深远影响。AF是血栓栓塞性中风的重要危险因素;并且还独立增加有或没有心血管疾病患者的总死亡率。临床实践中已实施各种风险分层方案,如CHADS和CHADS-VASc,以确定心源性栓塞性中风的风险以及AF患者进行血栓预防的必要性。AF还与其他心血管和外周血管疾病的病理生理学密切相关。鉴于动脉粥样硬化的许多危险因素也易患AF,许多AF患者伴有动脉粥样硬化。心肌梗死(MI)也与AF密切相关,其临床病程受新发AF的影响。本综述阐明了AF对与中风、冠状动脉疾病和外周血管疾病相关的主要不良心血管事件和死亡率结局的影响。

相似文献

1
Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.心房颤动患者中血管疾病影响下的中风与死亡预测
J Atr Fibrillation. 2012 Jun 15;5(1):586. doi: 10.4022/jafib.586. eCollection 2012 Jun-Jul.
2
Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?慢性肾脏病是否提高 CHADS2 和 CHA2DS2-VASc 卒中分层风险评分预测房颤的价值?
Thromb Haemost. 2013 May;109(5):956-60. doi: 10.1160/TH13-01-0054. Epub 2013 Mar 21.
3
The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.风险评分(CHADS2与CHA2DS2-VASc)对心房颤动消融术后长期预后的影响。
Heart Rhythm. 2015 Apr;12(4):681-6. doi: 10.1016/j.hrthm.2014.12.034. Epub 2014 Dec 26.
4
The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.CHADS2和CHA2DS2-VASc评分可预测无房颤的高危患者的不良血管功能、缺血性卒中和心血管死亡:纳入PR间期延长的作用。
Atherosclerosis. 2014 Dec;237(2):504-13. doi: 10.1016/j.atherosclerosis.2014.08.026. Epub 2014 Aug 30.
5
Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.中风前 CHADS2 和 CHA2DS2-VASc 评分可用于分层伴有和不伴有心房颤动的患者三个月结局。
Cerebrovasc Dis. 2013;36(4):273-80. doi: 10.1159/000353670. Epub 2013 Oct 16.
6
Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.肾功能障碍、卒中风险评分(CHADS2、CHA2DS2-VASc 和 R2CHADS2)与心房颤动导管消融术后血栓栓塞事件风险:莱比锡心脏中心房颤消融登记研究。
Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.
7
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS to the CHADS-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry.在采用CHADS-VASc评分替代CHADS评分进行血栓栓塞风险评估的指南推荐更改后,低至中度卒中风险心房颤动患者口服抗凝药处方的当代趋势:来自国家心血管数据注册中心门诊实践创新与临床卓越心房颤动注册研究的分析
Circ Cardiovasc Qual Outcomes. 2017 May;10(5). doi: 10.1161/CIRCOUTCOMES.116.003476.
8
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.在接受抗凝治疗的房颤患者中,HAS-BLED 评分对大出血的预测准确性优于 CHADS2 或 CHA2DS2-VASc 评分。
J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.
9
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.评估 CHA2DS2-VASc 评分在伴有和不伴有心房颤动的心力衰竭患者中预测缺血性卒、血栓栓塞和死亡的价值。
JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725.
10
CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.CHADS2、CHA2DS2-VASc和HAS-BLED作为接受经皮冠状动脉介入治疗的房颤患者预后的预测指标。
Thromb Res. 2014 Apr;133(4):560-6. doi: 10.1016/j.thromres.2014.01.007. Epub 2014 Jan 11.

引用本文的文献

1
Prediction of Atrial Fibrillation by B-type Natriuretic Peptide.B型利钠肽对心房颤动的预测作用
J Atr Fibrillation. 2013 Apr 6;5(6):674. doi: 10.4022/jafib.674. eCollection 2013 Apr-May.

本文引用的文献

1
Role of inflammation in early atrial fibrillation recurrence.炎症在早期心房颤动复发中的作用。
Europace. 2012 Jun;14(6):810-7. doi: 10.1093/europace/eur402. Epub 2012 Jan 10.
2
High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial.高敏 C 反应蛋白、他汀类药物治疗与心房颤动风险:JUPITER 试验的探索性分析。
Eur Heart J. 2012 Feb;33(4):531-7. doi: 10.1093/eurheartj/ehr460. Epub 2011 Dec 20.
3
What fans the fire: insights into mechanisms of inflammation in atherosclerosis and diabetes mellitus.火上浇油:动脉粥样硬化和糖尿病炎症机制的见解
Circulation. 2011 Dec 20;124(25):2809-11. doi: 10.1161/CIRCULATIONAHA.111.070565.
4
White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study).白细胞计数与心房颤动事件风险(来自弗雷明汉心脏研究)。
Am J Cardiol. 2012 Feb 15;109(4):533-7. doi: 10.1016/j.amjcard.2011.09.049. Epub 2011 Nov 17.
5
The prognostic value of atrial fibrillation on 30-day clinical outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.心房颤动对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者30天临床结局的预后价值。
Int Heart J. 2011;52(3):153-8. doi: 10.1536/ihj.52.153.
6
Pre-admission CHADS2 score is related to severity and outcome of stroke.入院前 CHADS2 评分与中风的严重程度和结局有关。
J Neurol Sci. 2011 Aug 15;307(1-2):149-52. doi: 10.1016/j.jns.2011.04.018. Epub 2011 May 12.
7
Atrial fibrillation and death after myocardial infarction: risk marker or causal mediator?心肌梗死后的心房颤动与死亡:风险标志物还是因果中介因素?
Circulation. 2011 May 17;123(19):2063-5. doi: 10.1161/CIRCULATIONAHA.111.030171. Epub 2011 May 2.
8
Atrial fibrillation and death after myocardial infarction: a community study.心房颤动和心肌梗死后死亡:一项社区研究。
Circulation. 2011 May 17;123(19):2094-100. doi: 10.1161/CIRCULATIONAHA.110.990192. Epub 2011 May 2.
9
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.血浆血管性血友病因子水平是抗凝治疗的心房颤动患者不良事件(包括死亡和大出血)的独立危险因素。
J Am Coll Cardiol. 2011 Jun 21;57(25):2496-504. doi: 10.1016/j.jacc.2010.12.033. Epub 2011 Apr 14.
10
Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study.炎症敏感蛋白与心房颤动风险:一项基于人群的队列研究。
Eur J Epidemiol. 2011 Jun;26(6):449-55. doi: 10.1007/s10654-011-9565-6. Epub 2011 Mar 19.